Page 160 - 南京医科大学自然版

第46卷第10期
·1590 · 南 京 医 科 大 学 学 报 2026年10月

反应。这一进展为哮喘患者提供了更为安全和高 Infect Dis，2024，78（4）：e37-e56
效的治疗选择。 ［12］Lengton R，Iyer A M，Van Der Valk E S，et al. Variation in
利益冲突声明： glucocorticoid sensitivity and the relation with obesity［J］.
所有作者声明无利益冲突。 Obes Rev，2022，23（3）：e13401
Conflict of Interests： ［13］Anastasilaki E，Paccou J，Gkastaris K，et al. Glucocorti⁃
coid⁃induced osteoporosis：an overview with focus on its
All the authors declare no conflicts of interests.
作者贡献声明： prevention and management［J］. Hormones，2023，22（4）：
丁紫琪负责文献检索、阅读及撰写文章。张倩负责文章 611-622
指导、修改并提供资金。 ［14］Ghiciuc C M，Vicovan A G，Stafie C S，et al. Marine⁃de⁃
Author’s Contributions： rived compounds for the potential treatment of glucocorti⁃
Ding Ziqi was responsible for literature retrieval，read⁃ing， coid resistance in severe asthma［J］. Mar Drugs，2021，19
（11）：586
and drafting the manuscript. Zhang Qian was responsible for
［15］Dixon E G，Rugg ⁃ Gunn C E，Sellick V，et al. Adverse
guidance and revision of the article，as well as providing funding.
drug reactions of leukotriene receptor antagonists in chil⁃
［参考文献］
dren with asthma：a systematic review［J］. BMJ Paediatr
［1］ Hammad H，Lambrecht B N. The basic immunology of Open，2021，5（1）：e001206
asthma［J］. Cell，2021，184（6）：1469-1485 ［16］Schleich F，Bougard N，Moermans C，et al. Cytokine⁃tar⁃
［2］ Hausen T. Hurdles on the way to the diagnosis of asthma geted therapies for asthma and COPD［J］. Eur Respir
and successful therapy［J］. Pneumologie，2025，79（2）： Rev，2023，32（168）：220193
153-160 ［17］Fu P，Long F，Hu S Y，et al. Rapid weaning from mechani⁃
［3］ Al Heialy S，Ramakrishnan R K，Hamid Q. Recent ad⁃ cal ventilation and bronchial thermoplasty for near⁃fatal
vances in the immunopathogenesis of severe asthma［J］. J asthma：a case report［J］. Heliyon，2023，9（5）：e15814
Allergy Clin Immunol，2022，149（2）：455-465 ［18］Shute J. Biomarkers of asthma［J］. Minerva Med，2022，
［4］ PELAIA C，MELHORN J，HINKS T S，et al. Type 2 113（1）：63-78
severe asthma：pathophysiology and treatment with bio⁃ ［19］Guida G，Carriero V，BertolinI F，et al. Exhaled nitric
logics［J］. Expert Rev Respir Med，2024，18（7）：485-498 oxide in asthma：from diagnosis to management［J］. Curr
［5］ Li Y，Wei X，Zhou Y，et al. Research progress of electronic Opin Allergy Clin Immunol，2023，23（1）：29-35
nose technology in exhaled breath disease analysis［J］. ［20］Hu J，Hu Y，Yao L，et al. A novel hybrid sensor array with
Microsyst Nanoeng，2023，9（1）：129 enhanced sensitivity and selectivity for biomarker detec⁃
［6］ Shadab A，Farokhi S，Fakouri A，et al. Hydrogel ⁃ based tion of multiple respiratory diseases［J］. Talanta，2026，
nanoparticles：revolutionizing brain tumor treatment and 300：129204
paving the way for future innovations［J］. Eur J Med Res， ［21］Licht J C，Grasemann H. Potential of the electronic nose
2025，30（1）：71 for the detection of respiratory diseases with and without
［7］ Ahmad A. Pharmacological strategies and recent advance⁃ infection［J］. Int J Mol Sci，2020，21（24）：9416
ment in nano⁃drug delivery for targeting asthma［J］. Life， ［22］Patil J，Sarasija S. Pulmonary drug delivery strategies：a
2022，12（4）：596 concise，systematic review［J］. Lung India，2012，29（1）：
［8］ Mansour H M，Muralidharan P，Hayes Jr D. Inhaled 44-49
nanoparticulate systems：composition，manufacture and ［23］Patra J K，Das G，Fraceto L F，et al. Nano based drug
aerosol delivery［J］. J Aerosol Med Pulm Drug Deliv， delivery systems：recent developments and future pros⁃
2024，37（4）：202-218 pects［J］. J Nanobiotechnology，2018，16（1）：71
［9］ Goswami V，Sodhi K K，Singh C K. Innovative approaches to ［24］Fan P S，Sun M J，Qin D，et al. Nanosystems as curative
asthma treatment：harnessing nanoparticle technology［J］. platforms for allergic disorder management［J］. J Mater
Discov Nano，2025，20（1）：21 Chem B，2021，9（7）：1729-1744
［10］Aaron S D，Boulet L P，Reddel H K，et al. Underdiagnosis ［25］Zhang H H，Kuo W S，Tu P Y，et al. Enhancing lung re⁃
and overdiagnosis of asthma［J］. Am J Respir Crit Care covery：inhaled poly（lactic⁃co⁃glycolic）acid encapsulat⁃
Med，2018，198（8）：1012-1020 ing FTY720 and nobiletin for lipopolysaccharide⁃induced
［11］Chastain D B，Spradlin M，Ahmad H，et al. Unintended lung injury，with advanced inhalation tower technology［J］.
consequences：risk of opportunistic infections associated ACS Nano，2025，19（8）：7634-7649
with long⁃term glucocorticoid therapies in adults［J］. Clin ［26］Xu B，Li S，Shi R，et al. Multifunctional mesoporous silica